Abstract:Aims Obesity always leads to profound perturbation of metabolome. Metabolome studies enrich the knowledge on associations between endogenous metabolites and obesity, potentially providing innovative strategies for the development of novel anti‐obesity pharmacotherapy. This study aims to identify an endogenous metabolite that regulates energy expenditure and to explore its application for obesity treatment. Materials and Methods C57BL/6 mice were fed with a high‐fat and high‐cholesterol (HFC) diet, comprising 60% fat and 1.2% cholesterol, for 12 weeks to induce obesity. Significant metabolites were identified in the livers of both health and obese mice through comparative hepatic metabolomics analysis. Correlation between serum or adipose L‐aspartate level and body weight in obese mice, as well as human body mass index (BMI), was evaluated. In addition, saline or 200 mg/kg L‐aspartate was orally administrated to HFC diet mice and HFC diet‐induced obese mice for 6–7 weeks. Body weight, adipose tissue weight, glucose tolerance and liver damage were assessed to evaluate the effect on obesity prevention and treatment. Comprehensive lab animal monitoring system (CLAMS) and seahorse assay were employed to investigate the regulatory effect of L‐aspartate on energy metabolism in vivo and in vitro, respectively. 3T3‐L1 preadipocytes and murine white adipose tissue (WAT) were utilized to examine the impact of L‐aspartate on adipocyte adipogenesis and lipogenesis and cellular signalling pathway in vitro and in vivo. Results L‐aspartate, an approved drug for liver injury and chronic fatigue, was identified as an endogenous inducer of energy expenditure. Serum or adipose L‐aspartate levels were found to be negatively correlated with the severity of obesity in both humans and mice. Administration of L‐aspartate to HFC diet mice led to a significant reduction in body weight, with decreases of 14.5% in HFC diet mice and 8.5% in HFC diet‐induced obese mice, respectively. In addition, the treatment improved related metabolic syndrome (Figure 2 and Figure S3). These therapeutics were associated with enhancements in whole‐body energy expenditure and suppression of adipocyte adipogenesis along with activation of Adenosine 5′‐monophosphate‐activated protein kinase (AMPK) signalling pathway. Conclusion L‐aspartate may serve as a novel endogenous inducer of energy expenditure and suppressor of adipogenesis and lipogenesis along with activation of AMPK, thereby offering a promising therapeutic strategy for obesity prevention and treatment.

Asparagine reinforces mTORC1 signaling to boost thermogenesis and glycolysis in adipose tissues

Aspartate restrains thermogenesis by inhibiting the AMPK pathway in adipose tissues

Amino acids contribute to adaptive thermogenesis. New insights into the mechanisms of action of recent drugs for metabolic disorders are emerging

Acteoside Improves Adipocyte Browning by CDK6-mediated Mtorc1-Tfeb Pathway

Guanidinoacetic acid ameliorates hepatic steatosis and inflammation and promotes white adipose tissue browning in middle-aged obese mice induced by a high-fat diet

Asparagine restriction enhances CD8 + T cell metabolic fitness and antitumoral functionality through an NRF2-dependent stress response

l -Theanine Activates the Browning of White Adipose Tissue Through the AMPK/α-Ketoglutarate/Prdm16 Axis and Ameliorates Diet-Induced Obesity in Mice

Angiogenesis–Browning Interplay Mediated by Asprosin-Knockout Contributes to Weight Loss in Mice with Obesity

L‐aspartate ameliorates diet‐induced obesity by increasing adipocyte energy expenditure

Reduced adipocyte glutaminase activity promotes energy expenditure and metabolic health

AMP-Activated Protein Kinase (AMPK) Regulates Energy Metabolism through Modulating Thermogenesis in Adipose Tissue.

Actein ameliorates diet-induced obesity through the activation of AMPK-mediated white fat browning

BCAA-nitrogen flux in brown fat controls metabolic health independent of thermogenesis

Spermidine/spermine N1-acetyltransferase-mediated polyamine catabolism regulates beige adipocyte biogenesis

Glutamine Production by Glul Promotes Thermogenic Adipocyte Differentiation Through Prdm9-Mediated H3K4me3 and Transcriptional Reprogramming

Overexpression of Adiponectin Receptor 1 Inhibits Brown and Beige Adipose Tissue Activity in Mice

L-Arginine increases AMPK phosphorylation and the oxidation of energy substrates in hepatocytes, skeletal muscle cells, and adipocytes

N-acetylaspartate pathway is nutrient responsive and coordinates lipid and energy metabolism in brown adipocytes

The miR-182-5p/FGF21/acetylcholine axis mediates the crosstalk between adipocytes and macrophages to promote beige fat thermogenesis

89-OR: GPSM1 Regulates ER Ca2+-Myosin II Axis and Promotes Adipocyte Browning and Metabolic Health

Increased thermogenesis by a noncanonical pathway in ANGPTL3/8-deficient mice